Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 October 2005:
Vol. 310. no. 5746, pp. 306 - 310
DOI: 10.1126/science.1118947
Prev | Table of Contents | Next

Reports

Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3

Tai-Lung Cha,1,2* Binhua P. Zhou,1{dagger} Weiya Xia,1 Yadi Wu,1 Cheng-Chieh Yang,1,2 Chun-Te Chen,1 Bo Ping,1 Arie P. Otte,3 Mien-Chie Hung1,2{ddagger}

Enhancer of Zeste homolog 2 (EZH2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone H3. Here, we show that Akt phosphorylates EZH2 at serine 21 and suppresses its methyltransferase activity by impeding EZH2 binding to histone H3, which results in a decrease of lysine 27 trimethylation and derepression of silenced genes. Our results imply that Akt regulates the methylation activity, through phosphorylation of EZH2, which may contribute to oncogenesis.

1 Department of Molecular and Cellular Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
2 Graduate School of Biomedical Sciences, the University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
3 Swammerdam Institute for Life Sciences, University of Amsterdam, Kruislaan 406, 1098 SM Amsterdam, the Netherlands.

* Present address: Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, National Defense University, Taipei, 104, Taiwan.

{dagger} Present address: Sealy Center for Cancer Cell Biology, the University of Texas Medical Branch, Galveston, TX 77555–1048, USA.

{ddagger} To whom correspondence should be addressed. E-mail: mhung{at}mdanderson.org

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Alterations of histone modifications by cobalt compounds.
Q. Li, Q. Ke, and M. Costa (2009)
Carcinogenesis 30, 1243-1251
   Abstract »    Full Text »    PDF »
Effects of Akt signaling on nuclear reprogramming.
T. Nakamura, K. Inoue, S. Ogawa, H. Umehara, N. Ogonuki, H. Miki, T. Kimura, A. Ogura, and T. Nakano (2008)
Genes Cells 13, 1269-1277
   Abstract »    Full Text »    PDF »
Arsenite alters global histone H3 methylation.
X. Zhou, H. Sun, T. P. Ellen, H. Chen, and M. Costa (2008)
Carcinogenesis 29, 1831-1836
   Abstract »    Full Text »    PDF »
Regulators of Cellular Levels of Histone Acetylation in Saccharomyces cerevisiae.
W. Peng, C. Togawa, K. Zhang, and S. K. Kurdistani (2008)
Genetics 179, 277-289
   Abstract »    Full Text »    PDF »
New insights into PTEN.
T. Tamguney and D. Stokoe (2007)
J. Cell Sci. 120, 4071-4079
   Abstract »    Full Text »    PDF »
High Histone Acetylation and Decreased Polycomb Repressive Complex 2 Member Levels Regulate Gene Specific Transcriptional Changes During Early Embryonic Stem Cell Differentiation Induced by Retinoic Acid.
E. R. Lee, F. E. Murdoch, and M. K. Fritsch (2007)
Stem Cells 25, 2191-2199
   Abstract »    Full Text »    PDF »
PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer.
Y. Watanabe, M. Toyota, Y. Kondo, H. Suzuki, T. Imai, M. Ohe-Toyota, R. Maruyama, M. Nojima, Y. Sasaki, Y. Sekido, et al. (2007)
Clin. Cancer Res. 13, 4786-4794
   Abstract »    Full Text »    PDF »
Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1.
K. Higashimoto, P. Kuhn, D. Desai, X. Cheng, and W. Xu (2007)
PNAS 104, 12318-12323
   Abstract »    Full Text »    PDF »
Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma.
C. Lu, T. Bonome, Y. Li, A. A. Kamat, L. Y. Han, R. Schmandt, R. L. Coleman, D. M. Gershenson, R. B. Jaffe, M. J. Birrer, et al. (2007)
Cancer Res. 67, 1757-1768
   Abstract »    Full Text »    PDF »
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases.
M. A. Bogoyevitch and B. Kobe (2006)
Microbiol. Mol. Biol. Rev. 70, 1061-1095
   Abstract »    Full Text »    PDF »
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
W. Fiskus, M. Pranpat, M. Balasis, B. Herger, R. Rao, A. Chinnaiyan, P. Atadja, and K. Bhalla (2006)
Mol. Cancer Ther. 5, 3096-3104
   Abstract »    Full Text »    PDF »
Systems Biology of AGC Kinases in Fungi.
A. Sobko (2006)
Sci. STKE 2006, re9
   Abstract »    Full Text »    PDF »
Dominant-Negative Histone H3 Lysine 27 Mutant Derepresses Silenced Tumor Suppressor Genes and Reverses the Drug-Resistant Phenotype in Cancer Cells.
P. H. Abbosh, J. S. Montgomery, J. A. Starkey, M. Novotny, E. G. Zuhowski, M. J. Egorin, A. P. Moseman, A. Golas, K. M. Brannon, C. Balch, et al. (2006)
Cancer Res. 66, 5582-5591
   Abstract »    Full Text »    PDF »
Wnt signaling: is the party in the nucleus?.
K. Willert and K. A. Jones (2006)
Genes & Dev. 20, 1394-1404
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)